Cargando…
Expression of concern: ‘Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial’
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423443/ https://www.ncbi.nlm.nih.gov/pubmed/37571965 http://dx.doi.org/10.1177/17534666231190750 |
Ejemplares similares
-
Two-day versus seven-day course of levofloxacin in
acute COPD exacerbation: a randomized controlled trial
por: Messous, Salma, et al.
Publicado: (2022) -
Expression of Concern: Immune Protection Induced on Day 10 Following Administration of the 2009 A/H1N1 Pandemic Influenza Vaccine
Publicado: (2012) -
Expression of Concern: Acute Omental Infarction Mimicking Acute Appendicitis
por: Owedah, Rahaf J, et al.
Publicado: (2022) -
Expression of Concern: Malaria in Dielmo, a Senegal village: Is its elimination possible after seven years of implementation of long-lasting insecticide-treated nets?
Publicado: (2022) -
Expression of Concern: Protective effect of autophagy on endoplasmic reticulum stress-induced apoptosis of alveolar epithelial cells in rat models of COPD
Publicado: (2020)